RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Intersect Ent Stock

Intersect Ent ROA 2024

Intersect Ent ROA

-1.09

Ticker

XENT

ISIN

US46071F1030

WKN

A117WV

In 2024, Intersect Ent's return on assets (ROA) was -1.09, a 0% increase from the 0 ROA in the previous year.

Intersect Ent Aktienanalyse

What does Intersect Ent do?

Intersect ENT Inc. is a biotechnology company specializing in the development of innovative therapies and devices for the treatment of chronic sinusitis and other nasal cavity disorders. The company was founded in 2003 and is headquartered in Menlo Park, California. The company's history began with the development of a novel implant system designed to provide effective and gentle treatment for chronic sinusitis. In 2012, the first product called PROPEL mini was launched, which serves as a two-part system for placement in the patient's sinuses. The implant ensures faster recovery after delicate surgeries and prevents adhesions. This innovation has revolutionized the way chronic sinusitis is treated. The PROPEL technology consists of a biodegradable polymer that gradually breaks down in the patient's body. It is available in various sizes and shapes to cater to the individual needs of each patient. In addition to the PROPEL technology, Intersect ENT also has other products in their portfolio targeting nasal cavity disorders. These include the SINUVA implant, used in patients with nasal polyps, as well as various devices for nasal perforation. Intersect ENT's business strategy is focused on maintaining and expanding their leadership in nasal healthcare innovation. The company heavily invests in research and development to create new products and technologies that meet medical needs and can improve patients' lives. To promote the sale of their products, Intersect ENT has built a comprehensive distribution network consisting of their own sales representatives and independent contract partners. The company collaborates closely with medical professionals and healthcare facilities to test and validate the effectiveness of their products. Intersect ENT is a company with a clear focus on innovation and excellence in product development. Their goal is to revolutionize the treatment of nasal diseases while providing patients with a better quality of life. With their groundbreaking technologies and extensive expertise, Intersect ENT has become a leading provider of nasal cavity solutions and is highly esteemed in the industry. Intersect Ent ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Intersect Ent's Return on Assets (ROA)

Intersect Ent's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Intersect Ent's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Intersect Ent's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Intersect Ent’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Intersect Ent stock

What is the Return on Assets (ROA) of Intersect Ent this year?

The Return on Assets (ROA) of Intersect Ent is -1.09 undefined this year.

What was the ROA of Intersect Ent compared to the previous year?

The ROA of Intersect Ent has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Intersect Ent?

A high ROA is advantageous for investors of Intersect Ent, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Intersect Ent?

A low ROA can be unfavorable for investors of Intersect Ent as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Intersect Ent affect the company?

An increase in ROA of Intersect Ent can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Intersect Ent impact the company?

A reduction in the ROA of Intersect Ent can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Intersect Ent?

Some factors that can influence the ROA of Intersect Ent include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Intersect Ent important for investors?

The ROA of Intersect Ent is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Intersect Ent take to improve ROA?

To improve ROA, Intersect Ent can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Intersect Ent pay?

Over the past 12 months, Intersect Ent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intersect Ent is expected to pay a dividend of 0 USD.

What is the dividend yield of Intersect Ent?

The current dividend yield of Intersect Ent is .

When does Intersect Ent pay dividends?

Intersect Ent pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intersect Ent?

Intersect Ent paid dividends every year for the past 0 years.

What is the dividend of Intersect Ent?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intersect Ent located?

Intersect Ent is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intersect Ent kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intersect Ent from 10/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/10/2024.

When did Intersect Ent pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Intersect Ent in the year 2023?

In the year 2023, Intersect Ent distributed 0 USD as dividends.

In which currency does Intersect Ent pay out the dividend?

The dividends of Intersect Ent are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Intersect Ent

Our stock analysis for Intersect Ent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intersect Ent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.